Aibili Logo Association for Innovation and Biomedical Research on Light

Ongoing Projects


Centre for Clinical Trials

E3 Consortium to promote and sustain collaboration and sharing of data and knowledge in the field of ophthalmic epidemiology in Europe. E3 [more info]

A single arm, open-label, multicenter study evaluating the long-term safety and tolerability of 0.5mg fingolimod (FTY720) administered orally once daily in patients with relapsing forms of multiple sclerosis (Protocol CTFY720D2399) [more info]

Randomized, open label multi-center study comparing cabazitaxel at 25 mg/m2 in combination with prednisone every 3 weeks to Docexatel in combination with prednisone in patients with metastatic castration resistant prostate cancer not pre-treated with chemotherapy (Firstana) (Protocol EFC11784) [more info]

A 24-month, phase IIIb, open-label, single arm, multicenter study assessing the efficacy and safety of an individualized, stabilization criteria-driven PRN dosing regimen with 0.5-mg ranibizumab intravitreal injections applied as monotherapy in patients with visual impairment due to macular edema secondary to central retinal vein occlusion (CRVO) (Protocol CRFB002E2401) [more info]

A 24-month, phase IIIb, open-label, randomized, active-controlled, 3-arm, multicenter study assessing the efficacy and safety of an individualized, stabilization-criteria-driven PRN dosing regimen with 0,5mg ranibizumab intravitreal injections applied as monotheraphy or with adjunctive laser photocoagulation in comparison to laser photocoagulation in patients with visual impairment due to macular edema secondary to branch vein occlusion (BRVO) (Protocol CRFB002E2402) [more info]

Prospective, Non-Intervencional, Longitudinal Cohort Study to evaluate the long-term safety of XALATAN® Treatment in Pediatric Populations (Protocol A6111143)) [more info]

Safety and IOP-Lowering Efficacy of Brinzolamide 10 mg/mL / Brimonidine 2 mg/mL Fixed Combination Eye Drops, Suspension compared to Brinzolamide 10 mg/mL Eye Drops, Suspension and Brimonidine 2 mg/mL Eye Drops, Solution in Patients with Open-Angle Glaucoma or Ocular Hypertension (Protocol C-10-040) [more info]

A phase III, randomized, double-masked 6-month clinical study to compare the efficacy and safety of the preservative-free fixed dose combination of tafluprost 0.0015% and timolol 0.5% eye drops to those of tafluprost 0.0015% and timolol 0.5% eye drops given concomitantly in patients with open angle glaucoma or ocular hypertension (Protocol 201051) [more info]

A Retrospective non-interventional study to assess the effectiveness of existing anti-vascular endothelial growth factor (anti-VEGF) treatment regimens in patients with wet age-related macular degeneration (Review) (Protocol 16378) [more info]

Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes (Luminous) (Protocol RFB002A2406) [more info]

1 2 3

Projects by department:

  -   Cloud   -  Copyright © AIBILI   -   Contact Us   -   Site Map   -   Privacy Policy  -  Cookies Policy  -  Webdesign Glitz Design   -   Programming Bizview